In this articlewe reviewedthe advances in clinicalstudy of imatinib including itsmechanism of resistance, adverse events, lifequalitystudy and cost-effectiveanalysis, etc.
In one analysis by the Office of Management and Budget, of the 30 least cost-effective regulations throughout the government, the EPA had imposed no fewer than 17.